Coherus CFO Stilwell resigns; EVP McMichael named Interim CFO

Coherus Oncology, Inc.

McDavid Stilwell resigned as CFO and Principal Financial Officer, effective Dec 31, 2023, to pursue other opportunities.
Bryan McMichael appointed Interim CFO and Principal Financial Officer, effective Dec 8, 2023.
McMichael continues as EVP, Accounting, Corporate Controller and Principal Accounting Officer; previously at Gilead Sciences.
No compensatory changes or grants in connection with the interim appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Bryan McMichael

Interim Chief Financial Officer and Principal Financial Officer

CHRS · Coherus Oncology, Inc.

Effective: 2023-12-08
Filed: December 11, 2023, 6:59 PM ET

The Board of Directors of the Company appointed Bryan McMichael, age 45, to serve as the Company’s Interim Chief Financial Officer and Principal Financial Officer effective December 8, 2023.

Departed

McDavid Stilwell

Chief Financial Officer, Principal Financial Officer

CHRS · Coherus Oncology, Inc.

Effective: 2023-12-31
Successor: Bryan McMichael
Filed: December 11, 2023, 6:59 PM ET

McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Bryan McMichael was appointed as Interim Chief Financial Officer and Principal Financial Officer at Coherus Oncology, Inc..

Action: appointed
Role: Interim Chief Financial Officer and Principal Financial Officer

Exact text from the filing

The Board of Directors of the Company appointed Bryan McMichael, age 45, to serve as the Company’s Interim Chief Financial Officer and Principal Financial Officer effective December 8, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

McDavid Stilwell resigned as Chief Financial Officer, Principal Financial Officer at Coherus Oncology, Inc..

Action: resigned
Role: Chief Financial Officer, Principal Financial Officer

Exact text from the filing

McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.

View on SEC.gov

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-019713

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.